Dr. Kevin Zhao joined AGADA as a senior research associate in 2020, primarily engaged in conducting animal work for preclinical trials and performing bioanalytical testing and analysis for clinical trials. He transitioned to a research scientist in 2021, specializing in bioanalytical development, validation, and clinical sample analysis.
In 2022, Kevin became the director of clinical research where he is deeply committed to advancing biomarker development and testing for clinical trials.